Search Results - Alexander Starr

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD

    Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD by Alexander Starr, Rita Sattler

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS

    Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS by Alyssa N. Coyne, Ileana Lorenzini, Ching‐Chieh Chou, Meaghan Torvund, Robert S. Rogers, Alexander Starr, Benjamin L. Zaepfel, Jennifer Lévy, Jeffrey Johannesmeyer, Jacob C. Schwartz, Hiroshi Nishimune, Konrad E. Zinsmaier, Wilfried Rossoll, Rita Sattler, Daniela C. Zarnescu

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS

    Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS by Ernesto Manzo, Ileana Lorenzini, Dianne Barrameda, Abigail G O'Conner, Jordan M. Barrows, Alexander Starr, Tina Kovalik, Benjamin E. Rabichow, Erik M. Lehmkuhl, Dakotah D. Shreiner, Archi Joardar, Jean-Charles Liévens, Robert Bowser, Rita Sattler, Daniela C. Zarnescu

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD

    ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD by Stephen Moore, Eric Alsop, Ileana Lorenzini, Alexander Starr, Benjamin E. Rabichow, Emily Méndez, Jennifer L. Levy, Camelia Burciu, Rebecca Reiman, Jeannie Chew, Véronique Belzil, Dennis W. Dickson, Janice Robertson, Kim A. Staats, Justin K. Ichida, Leonard Petrucelli, Kendall Van Keuren‐Jensen, Rita Sattler

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival

    Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with... by Denise A. Yardley, Peter A. Kaufman, Weidong Huang, Lea Krekow, Michael A. Savin, William Lawler, Stephen Zrada, Alexander Starr, Harvey Einhorn, Lee S. Schwartzberg, John W. Adams, Yolanda Lie, Agnès Paquet, Jeff Sperinde, Mojgan Haddad, Steve Anderson, Marlon Brigino, Rick L. Pesano, Michael Bates, Jodi Weidler, Linda D. Bosserman

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab

    Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab by Lee S. Schwartzberg, Kurt W. Tauer, Robert C. Hermann, Grace Makari‐Judson, Claudine Isaacs, J. Thaddeus Beck, Virginia Kaklamani, Edward J. Stepanski, Hope S. Rugo, Wei Wang, Katherine M. Bell‐McGuinn, Jeffrey J. Kirshner, Peter Eisenberg, Richard Emanuelson, Mark Keaton, Ellis Levine, Diana C. Medgyesy, Rubina Qamar, Alexander Starr, Sunhee Ro, Nathalie A. Lokker, Clifford A. Hudis

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: